Status:
RECRUITING
Orthorexia Nervosa in Postmenopausal Osteoporosis
Lead Sponsor:
Beylikduzu State Hospital
Conditions:
Osteoporosis
Eligibility:
FEMALE
55-75 years
Brief Summary
A total of 64 female patients diagnosed with osteoporosis based on dual-energy X-ray absorptiometry (DXA) measurements performed within the last six months, and 64 age-matched healthy controls without...
Eligibility Criteria
Inclusion
- Women between 55-75 years
- Women diagnosed with osteoporosis based on DXA measurements performed within the past six months.
- Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls).
- Willingness to participate and provision of written informed consent.
Exclusion
- Refusal to participate in the study.
- Diagnosed psychiatric disorders.
- Cognitive impairment.
- Presence of malignancy.
- Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome).
- Use of glucocorticoids.
- Use of medications affecting mood.
Key Trial Info
Start Date :
April 20 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 20 2025
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT06947213
Start Date
April 20 2025
End Date
May 20 2025
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beylikdüzü State Hospital
Istanbul, Turkey (Türkiye), 34147